Calcium hydroxyapatite filler is used in aesthetics for facial wrinkles, and may also be helpful in treating volume loss in the anophthalmic socket following enucleation or evisceration. Source: AAO
A perfluorohexyloctane ophthalmic drop appears to offer significant relief from dry eye signs and symptoms according to the results of the MOJAVE clinical study. Source: AAO
Medical students and residents can learn about ophthalmology with a case-based online tool, fibrin glue reduces ecchymosis severity after surgery, insurance coverage is no guarantee of regular pediatric vision testing, and once-weekly eye drops are in active development. Source: AAO
A phase 3 trial reveals similar performance between aflibercept and an aflibercept biosimilar for the treatment of neovascular AMD. Source: AAO
Signs and symptoms of mild-to-moderate meibomian gland disease show improvement in this phase 2 trial of a selenium sulfide ophthalmic ointment. Source: AAO
While conversion from esotropia to nonsurgical exotropia in children is rare, hyperopia is not necessarily the cause of this phenomenon. Source: AAO
Sight-impaired commuters may be able to negotiate subways via an app, a new treatment for AMD-related geographic atrophy (GA) is approved, high fat intake could increase DR risk, and more. Source: AAO
Blue light–filtering IOLs help reduce new glaucoma after cataract surgery, 3D scaffolding supports longer-lasting cultured RPE cells, and niacin intake could reduce glaucoma risk in women. Source: AAO
For treating persistent uveitic macular edema, the dexamethasone implant remains the superior choice in comparison to repeated ranibizumab or methotrexate injections. Source: AAO
The first blepharitis treatment targeting Demodex mites is approved, women ask fewer questions during ophthalmology grand rounds than men, short-term statin use does not increase glaucoma risk, and the TEPEZZA label adds warnings about hearing-related events. Source: AAO